Dr. Nilda Lopez, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,106 | 123 | 99.4% |
| Education | $11.90 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $336.01 | 24 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $305.55 | 18 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $218.05 | 13 | $0 (2020) |
| Allergan, Inc. | $190.29 | 14 | $0 (2020) |
| GM Pharmaceuticals, Inc. | $153.59 | 1 | $0 (2020) |
| Pacira Pharmaceuticals Incorporated | $125.00 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $86.78 | 6 | $0 (2020) |
| Gilead Sciences, Inc. | $72.27 | 4 | $0 (2020) |
| KVK-Tech, Inc. | $71.79 | 4 | $0 (2019) |
| Shire North American Group Inc | $67.71 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.13 | 1 | ABBVIE INC. ($13.13) |
| 2021 | $26.56 | 2 | Genentech USA, Inc. ($14.00) |
| 2020 | $794.84 | 44 | Allergan, Inc. ($167.47) |
| 2019 | $323.34 | 13 | Pacira Pharmaceuticals Incorporated ($125.00) |
| 2018 | $586.41 | 39 | Novo Nordisk Inc ($132.69) |
| 2017 | $373.56 | 25 | AstraZeneca Pharmaceuticals LP ($122.32) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Virology & Specialty Care | ||||||
| 10/22/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRIJARDY XR | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: DIABETES | ||||||
| 10/19/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: Bone Health | ||||||
| 10/16/2020 | Arbor Pharmaceuticals, Inc. | Edarbyclor (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Neuroscience | ||||||
| 10/12/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 10/08/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2020 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: HIV | ||||||
| 09/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/22/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 09/17/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2020 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: OBESITY | ||||||
| 08/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/07/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.09 | General |
| 08/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/03/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: DIABETES | ||||||
| 07/16/2020 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: OBESITY | ||||||
| 07/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 62 | 63 | $16,226 | $3,444 |
| 2021 | 4 | 69 | 69 | $17,327 | $5,559 |
| 2020 | 3 | 61 | 93 | $33,510 | $5,539 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $6,930 | $1,447 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 28 | $6,440 | $1,447 | 22.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 14 | 14 | $2,856 | $549.58 | 19.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $5,940 | $1,710 | 28.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 21 | $4,787 | $1,555 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $3,674 | $1,318 | 35.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 19 | 19 | $2,926 | $974.89 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 66 | $28,710 | $4,448 | 15.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 15 | $4,380 | $899.81 | 20.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 12 | 12 | $420.00 | $191.33 | 45.6% |
About Dr. Nilda Lopez, M.D
Dr. Nilda Lopez, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1659662930.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nilda Lopez, M.D has received a total of $2,118 in payments from pharmaceutical and medical device companies, with $13.13 received in 2023. These payments were reported across 124 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,106).
As a Medicare-enrolled provider, Lopez has provided services to 192 Medicare beneficiaries, totaling 225 services with total Medicare billing of $14,542. Data is available for 3 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Fort Worth, TX
- Active Since 04/21/2011
- Last Updated 12/12/2012
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1659662930
Products in Payments
- FARXIGA (Drug) $305.55
- JARDIANCE (Drug) $218.05
- Saxenda (Drug) $163.69
- Vanacof (Drug) $153.59
- EXPAREL (Drug) $125.00
- XIFAXAN (Drug) $98.84
- UBRELVY (Drug) $82.03
- VRAYLAR (Drug) $78.22
- Descovy (Drug) $52.10
- CONTRAVE (Drug) $50.71
- VYVANSE (Drug) $49.78
- LINZESS (Drug) $42.60
- Xofluza (Drug) $35.65
- TRULICITY (Drug) $35.32
- ADHANSIA XR (Drug) $27.29
- INVOKANA (Drug) $26.77
- Belviq (Drug) $26.07
- TUDORZA PRESSAIR (Drug) $20.44
- Edarbyclor (Drug) $18.96
- Mirena (Drug) $18.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Fort Worth
Dr. Richard Teames, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $679,444
Jeremy Ross, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $347,288
Brett Mueller, Do, Phd, DO, PHD
Student in an Organized Health Care Education/Training Program — Payments: $114,196
Herman Kao, Dds, Md, DDS, MD
Student in an Organized Health Care Education/Training Program — Payments: $57,014
Dr. Natalia Chaimowitz, M.d., Ph.d, M.D., PH.D
Student in an Organized Health Care Education/Training Program — Payments: $40,250
Dr. Joshua Payne, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $22,289